Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 5/20 | 0.36 |
| ▸ | HTR2A | P28223 | 3/20 | 0.35 |
| ▸ | HTR2C | P28335 | 3/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.34 |
| ▸ | PDE4A | P27815 | 2/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.34 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PDE5A | O76074 | 1/20 | 0.33 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21655245 | 0.95 | PTGDR2 (0.37) | ACACBPTGDR2 | |
| SCHEMBL20090382 | 0.90 | FFAR4 (0.34) | ACACBHTR2AHTR2CHTR2BRIPK1 | |
| SCHEMBL12113648 | 0.86 | HPGD (0.38) | HTR2AHTR2CHTR2BPTGDR2RIPK1 | |
| SCHEMBL20090390 | 0.85 | FFAR1 (0.36) | — | |
| SCHEMBL1311479 | 0.84 | RIPK1 (0.38) | ACACBHTR2AHTR2CHTR2BPTGDR2 | |
| SCHEMBL15381722 | 0.82 | ALOX5AP (0.40) | HTR2AHTR2CHTR2BSSTR5KCNH2 | |
| SCHEMBL15381684 | 0.82 | ALOX5AP (0.40) | HTR2AHTR2CHTR2BSSTR5KCNH2 | |
| SCHEMBL28755446 | 0.82 | RIPK1 (0.37) | HTR2AHTR2CHTR2BPTGDR2RIPK1 | |
| SCHEMBL11938870 | 0.81 | ALOX5AP (0.36) | SSTR5KCNH2 | |
| SCHEMBL11938848 | 0.81 | ALOX5AP (0.36) | SSTR5KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3670503-B1 | COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING SAME, AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO LTD (CN) | 2023-10-18 | — | — | EP | disclosed |
| US-11208395-B2 | Compound, liquid crystal medium containing the compound and application thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2021-12-28 | — | — | US | disclosed |
| EP-3670503-A1 | COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING SAME, AND USE THEREOF | Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd. (CN) | 2020-06-24 | — | — | EP | disclosed |
| US-20190345129-A1 | COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING THE COMPOUND AND APPLICATION THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345129-A1 | COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING THE COMPOUND AND APPLICATION THEREOF | ABCG2, TPST2, TST | ACACB 3411/4885HTR2A 2349/4885HTR2C 1336/4885 |
| US-11208395-B2 | Compound, liquid crystal medium containing the compound and application thereof | TST, TPST2, ABCG2 | ACACB 3458/4885HTR2A 2565/4885HTR2C 1452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.